SlideShare a Scribd company logo
1 of 10
GLOBAL SUMMIT ON INTELLECTUAL PROPERTY &
ACCESS TO MEDICINES
PATHWAYS TO ACCESS
15-17 January, 2018. Marrakesh, Morocco.
INPI ARGENTINA. Guidelines for Patentability Examination of patent
applications for chemical and pharmaceuticals inventions
TRIPS flexibilities: patentability criteria & policy coherence
Strict application
Strict interpretation
High standards
So…..
Year: 2012. Joint resolution. Why?
Ministry of Industry
Ministry of Health
National Industrial Property Institute of Argentina
-Jointly adopted guidelines for examination
-Instructions regarding the application of the patentability standards
in pharmaceutical field
The guidelines establish that :
new use,
new form,
new formulation patents, and
other changes to drugs
are not patentable
POLYMORPHS: is not a man made invention but a property of each substance
PSEUDOPOLYMORPHS ( hydrates and solvates)
ENANTIOMERS
MARKUSH- TYPE FORMULA
SELECTION PATENT APPLICATIONS
SALTS, ESTERES AND OTHER DERIVATIONS OF KNOWN SUBSTANCES
ACTIVE METABOLITES
PRODRUGS
FORMULATIONS AND COMPOSITIONS
COMBINATIONS
DOSAGE/DOSE
SECOND MEDICAL INDICATION
ANALOGOUS PROCESSES
guidelines + oppositions = high quality patents
PATENTS: FILINGS
0
1.000
2.000
3.000
4.000
5.000
6.000
7.000
8.000
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Local & Foreign Filings
(1995-2016)
Resident
17%
Non-resident
83%
4.017
7.033
GEORGINA GERDE
ggerde@inpi.gob.ar
INPI ARGENTINA
.
GEORGINA GERDE
ggerde@inpi.gob.ar
INPI ARGENTINA
.

More Related Content

What's hot

International Regulatory Overview 2009 Rev Linkedln
International Regulatory Overview   2009 Rev LinkedlnInternational Regulatory Overview   2009 Rev Linkedln
International Regulatory Overview 2009 Rev Linkedln
Mdbio
 
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIESREGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
Dhruvi Panchal
 

What's hot (20)

Ich guidelines QSEM suraj seminar
Ich guidelines  QSEM suraj seminarIch guidelines  QSEM suraj seminar
Ich guidelines QSEM suraj seminar
 
June 9 2017 Panel 5 Ravi Agarwal
June 9 2017 Panel 5 Ravi AgarwalJune 9 2017 Panel 5 Ravi Agarwal
June 9 2017 Panel 5 Ravi Agarwal
 
An introduction to the EMA
An introduction to the EMAAn introduction to the EMA
An introduction to the EMA
 
Ich quality guidelines
Ich quality guidelinesIch quality guidelines
Ich quality guidelines
 
Oecd ws-ip-pharma-italy-26feb19
Oecd ws-ip-pharma-italy-26feb19Oecd ws-ip-pharma-italy-26feb19
Oecd ws-ip-pharma-italy-26feb19
 
Disparagement against generics
Disparagement against genericsDisparagement against generics
Disparagement against generics
 
Regulatory requirments of eu, tga & row countries
Regulatory requirments of eu, tga  & row countriesRegulatory requirments of eu, tga  & row countries
Regulatory requirments of eu, tga & row countries
 
Introduction to pharmaceutical regulatory agencies
Introduction to pharmaceutical regulatory agenciesIntroduction to pharmaceutical regulatory agencies
Introduction to pharmaceutical regulatory agencies
 
INQUINAMENTO AMBIENTALE da FARMACI e sostanze attive
INQUINAMENTO AMBIENTALE da FARMACI e sostanze attiveINQUINAMENTO AMBIENTALE da FARMACI e sostanze attive
INQUINAMENTO AMBIENTALE da FARMACI e sostanze attive
 
Toward a Toxic Partnership - A critique of the EU position on chemicals under...
Toward a Toxic Partnership - A critique of the EU position on chemicals under...Toward a Toxic Partnership - A critique of the EU position on chemicals under...
Toward a Toxic Partnership - A critique of the EU position on chemicals under...
 
Pharmaceutical impurties
Pharmaceutical impurtiesPharmaceutical impurties
Pharmaceutical impurties
 
Regulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packgingRegulatory aspect of pharamacutical packging
Regulatory aspect of pharamacutical packging
 
Therapeutics goods administration & Row Countries
Therapeutics goods administration & Row CountriesTherapeutics goods administration & Row Countries
Therapeutics goods administration & Row Countries
 
European medicines agency
European medicines agencyEuropean medicines agency
European medicines agency
 
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.
 
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
 
EUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCYEUROPEAN MEDICAL AGENCY
EUROPEAN MEDICAL AGENCY
 
International Regulatory Overview 2009 Rev Linkedln
International Regulatory Overview   2009 Rev LinkedlnInternational Regulatory Overview   2009 Rev Linkedln
International Regulatory Overview 2009 Rev Linkedln
 
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIESREGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
REGULATORY REQUIREMENTS OF EU, MHRA, TGA AND RoW COUNTRIES
 
Regulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & IndiaRegulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & India
 

Similar to GSIPA2M, Parallel session 1, Preventing bad patents - Georgina Gerde

Similar to GSIPA2M, Parallel session 1, Preventing bad patents - Georgina Gerde (20)

GSIPA2M, Parallel session 1, Preventing bad patents - German Velasquez
GSIPA2M, Parallel session 1, Preventing bad patents - German VelasquezGSIPA2M, Parallel session 1, Preventing bad patents - German Velasquez
GSIPA2M, Parallel session 1, Preventing bad patents - German Velasquez
 
Polymorph patents
Polymorph patentsPolymorph patents
Polymorph patents
 
Pharmaceutical analysis From Metrohm
Pharmaceutical analysis From MetrohmPharmaceutical analysis From Metrohm
Pharmaceutical analysis From Metrohm
 
Gpat syllabus 2016
Gpat syllabus 2016Gpat syllabus 2016
Gpat syllabus 2016
 
regulatory affairs ip ii final
regulatory affairs  ip ii finalregulatory affairs  ip ii final
regulatory affairs ip ii final
 
Regulatory changes in clinical trials
Regulatory changes in clinical trialsRegulatory changes in clinical trials
Regulatory changes in clinical trials
 
DRUG REGULATORY AFFAIRS
DRUG REGULATORY AFFAIRS DRUG REGULATORY AFFAIRS
DRUG REGULATORY AFFAIRS
 
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
 
Irum naila
Irum nailaIrum naila
Irum naila
 
Precursor chemicals
Precursor chemicalsPrecursor chemicals
Precursor chemicals
 
Vish- Concept and Historical Development of Pharmaceutical Product Registration
Vish- Concept and Historical Development of Pharmaceutical Product RegistrationVish- Concept and Historical Development of Pharmaceutical Product Registration
Vish- Concept and Historical Development of Pharmaceutical Product Registration
 
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
JAPAN: ORGANISATION OF PMDA, PHARMACEUTICAL LAWS & REGULATIONS, TYPES OF REGI...
 
Drug regulatory affairs - 1
Drug regulatory affairs - 1Drug regulatory affairs - 1
Drug regulatory affairs - 1
 
ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...
ICH GUIDELINES  Q S E M & REGULATORY REQUIREMENTS  OF  EU, MHRA, TGA & ROW CO...ICH GUIDELINES  Q S E M & REGULATORY REQUIREMENTS  OF  EU, MHRA, TGA & ROW CO...
ICH GUIDELINES Q S E M & REGULATORY REQUIREMENTS OF EU, MHRA, TGA & ROW CO...
 
API, AFI – AN OVERVIEW BY DR AJITH KUMAR
API, AFI – AN OVERVIEW BY DR AJITH KUMARAPI, AFI – AN OVERVIEW BY DR AJITH KUMAR
API, AFI – AN OVERVIEW BY DR AJITH KUMAR
 
Regulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy IIRegulatory affairs - industrial pharmacy II
Regulatory affairs - industrial pharmacy II
 
Nda
NdaNda
Nda
 
Natural Products: The Case for a Product Development Paradigm in Malaysian Na...
Natural Products: The Case for a Product Development Paradigm in Malaysian Na...Natural Products: The Case for a Product Development Paradigm in Malaysian Na...
Natural Products: The Case for a Product Development Paradigm in Malaysian Na...
 
Basic concepts about regulatory affairs
Basic concepts about regulatory affairsBasic concepts about regulatory affairs
Basic concepts about regulatory affairs
 
Pharmaceutical Jurisprudence syllabus DCP-II
Pharmaceutical Jurisprudence syllabus DCP-IIPharmaceutical Jurisprudence syllabus DCP-II
Pharmaceutical Jurisprudence syllabus DCP-II
 

More from MakeMedicinesAffordable

More from MakeMedicinesAffordable (20)

GSIPA2M, Day 2 plenary panel - Karin Timmermans
GSIPA2M, Day 2 plenary panel - Karin TimmermansGSIPA2M, Day 2 plenary panel - Karin Timmermans
GSIPA2M, Day 2 plenary panel - Karin Timmermans
 
Rapporteur report - what we have heard.
Rapporteur report - what we have heard.Rapporteur report - what we have heard.
Rapporteur report - what we have heard.
 
GSIPA2M, A radical agenda? - German Velasquez
GSIPA2M, A radical agenda? - German VelasquezGSIPA2M, A radical agenda? - German Velasquez
GSIPA2M, A radical agenda? - German Velasquez
 
GSIPA2M, A radical agenda? - Michelle Childs
GSIPA2M, A radical agenda? - Michelle ChildsGSIPA2M, A radical agenda? - Michelle Childs
GSIPA2M, A radical agenda? - Michelle Childs
 
GSIPA2M, A radical agenda? - Jorge Bermudez
GSIPA2M, A radical agenda? - Jorge BermudezGSIPA2M, A radical agenda? - Jorge Bermudez
GSIPA2M, A radical agenda? - Jorge Bermudez
 
GSIPA2M, Day 2 plenary panel - Francisco Rossi
GSIPA2M, Day 2 plenary panel - Francisco RossiGSIPA2M, Day 2 plenary panel - Francisco Rossi
GSIPA2M, Day 2 plenary panel - Francisco Rossi
 
GSIPA2M, Day 2 plenary panel - Solange Baptiste
GSIPA2M, Day 2 plenary panel - Solange BaptisteGSIPA2M, Day 2 plenary panel - Solange Baptiste
GSIPA2M, Day 2 plenary panel - Solange Baptiste
 
GSIPA2M, Day 2 plenary panel - Jorrit Kabel
GSIPA2M, Day 2 plenary panel - Jorrit KabelGSIPA2M, Day 2 plenary panel - Jorrit Kabel
GSIPA2M, Day 2 plenary panel - Jorrit Kabel
 
GSIPA2M, Day 2 plenary panel - Tatiana Khan
GSIPA2M, Day 2 plenary panel - Tatiana KhanGSIPA2M, Day 2 plenary panel - Tatiana Khan
GSIPA2M, Day 2 plenary panel - Tatiana Khan
 
GSIPA2M, Roundtable 4, Challenging unmerited patents - Tahir Amin
GSIPA2M, Roundtable 4, Challenging unmerited patents - Tahir AminGSIPA2M, Roundtable 4, Challenging unmerited patents - Tahir Amin
GSIPA2M, Roundtable 4, Challenging unmerited patents - Tahir Amin
 
GSIPA2M, Roundtable 4, Challenging unmerited patents - Menna-t-allah M. El Ko...
GSIPA2M, Roundtable 4, Challenging unmerited patents - Menna-t-allah M. El Ko...GSIPA2M, Roundtable 4, Challenging unmerited patents - Menna-t-allah M. El Ko...
GSIPA2M, Roundtable 4, Challenging unmerited patents - Menna-t-allah M. El Ko...
 
GSIPA2M, Roundtable 4, Challenging unmerited patents - Georgina Gerde
GSIPA2M, Roundtable 4, Challenging unmerited patents - Georgina GerdeGSIPA2M, Roundtable 4, Challenging unmerited patents - Georgina Gerde
GSIPA2M, Roundtable 4, Challenging unmerited patents - Georgina Gerde
 
GSIPA2M, Roundtable 4, Challenging unmerited patents - Jose Maria di Bello
GSIPA2M, Roundtable 4, Challenging unmerited patents - Jose Maria di BelloGSIPA2M, Roundtable 4, Challenging unmerited patents - Jose Maria di Bello
GSIPA2M, Roundtable 4, Challenging unmerited patents - Jose Maria di Bello
 
GSIPA2M, Roundtable 4, Challenging unmerited patents - Sergey Kondratyuk
GSIPA2M, Roundtable 4, Challenging unmerited patents - Sergey KondratyukGSIPA2M, Roundtable 4, Challenging unmerited patents - Sergey Kondratyuk
GSIPA2M, Roundtable 4, Challenging unmerited patents - Sergey Kondratyuk
 
GSIPA2M, Roundtable 3, Pro-health law reform - Judit Rius Sanjuan
GSIPA2M, Roundtable 3, Pro-health law reform - Judit Rius SanjuanGSIPA2M, Roundtable 3, Pro-health law reform - Judit Rius Sanjuan
GSIPA2M, Roundtable 3, Pro-health law reform - Judit Rius Sanjuan
 
GSIPA2M, Rountable 3, Pro-health law reform - Oksana Kashyntseva
GSIPA2M, Rountable 3, Pro-health law reform - Oksana KashyntsevaGSIPA2M, Rountable 3, Pro-health law reform - Oksana Kashyntseva
GSIPA2M, Rountable 3, Pro-health law reform - Oksana Kashyntseva
 
GSIPA2M, Roundtable 2, Local production - Padmashree Gehl Sampath
GSIPA2M, Roundtable 2, Local production - Padmashree Gehl SampathGSIPA2M, Roundtable 2, Local production - Padmashree Gehl Sampath
GSIPA2M, Roundtable 2, Local production - Padmashree Gehl Sampath
 
GSIPA2M, Roundtable 2, Local production - Jorge Bermudez
GSIPA2M, Roundtable 2, Local production - Jorge BermudezGSIPA2M, Roundtable 2, Local production - Jorge Bermudez
GSIPA2M, Roundtable 2, Local production - Jorge Bermudez
 
GSIPA2M, Roundtable 2, Local production - Mia Lahlou Filali
GSIPA2M, Roundtable 2, Local production - Mia Lahlou Filali GSIPA2M, Roundtable 2, Local production - Mia Lahlou Filali
GSIPA2M, Roundtable 2, Local production - Mia Lahlou Filali
 
GSIPA2M, Roundtable 1, TRIPS-minus - Yunus Mohammed
GSIPA2M, Roundtable 1, TRIPS-minus - Yunus MohammedGSIPA2M, Roundtable 1, TRIPS-minus - Yunus Mohammed
GSIPA2M, Roundtable 1, TRIPS-minus - Yunus Mohammed
 

Recently uploaded

Competitive Advantage slide deck___.pptx
Competitive Advantage slide deck___.pptxCompetitive Advantage slide deck___.pptx
Competitive Advantage slide deck___.pptx
ScottMeyers35
 
Top profile Call Girls In Morena [ 7014168258 ] Call Me For Genuine Models We...
Top profile Call Girls In Morena [ 7014168258 ] Call Me For Genuine Models We...Top profile Call Girls In Morena [ 7014168258 ] Call Me For Genuine Models We...
Top profile Call Girls In Morena [ 7014168258 ] Call Me For Genuine Models We...
gajnagarg
 

Recently uploaded (20)

AHMR volume 10 number 1 January-April 2024
AHMR volume 10 number 1 January-April 2024AHMR volume 10 number 1 January-April 2024
AHMR volume 10 number 1 January-April 2024
 
Competitive Advantage slide deck___.pptx
Competitive Advantage slide deck___.pptxCompetitive Advantage slide deck___.pptx
Competitive Advantage slide deck___.pptx
 
Tuvalu Coastal Adaptation Project (TCAP)
Tuvalu Coastal Adaptation Project (TCAP)Tuvalu Coastal Adaptation Project (TCAP)
Tuvalu Coastal Adaptation Project (TCAP)
 
Top profile Call Girls In Morena [ 7014168258 ] Call Me For Genuine Models We...
Top profile Call Girls In Morena [ 7014168258 ] Call Me For Genuine Models We...Top profile Call Girls In Morena [ 7014168258 ] Call Me For Genuine Models We...
Top profile Call Girls In Morena [ 7014168258 ] Call Me For Genuine Models We...
 
NAP Expo - Delivering effective and adequate adaptation.pptx
NAP Expo - Delivering effective and adequate adaptation.pptxNAP Expo - Delivering effective and adequate adaptation.pptx
NAP Expo - Delivering effective and adequate adaptation.pptx
 
Call Girls Mehsana / 8250092165 Genuine Call girls with real Photos and Number
Call Girls Mehsana / 8250092165 Genuine Call girls with real Photos and NumberCall Girls Mehsana / 8250092165 Genuine Call girls with real Photos and Number
Call Girls Mehsana / 8250092165 Genuine Call girls with real Photos and Number
 
Finance strategies for adaptation. Presentation for CANCC
Finance strategies for adaptation. Presentation for CANCCFinance strategies for adaptation. Presentation for CANCC
Finance strategies for adaptation. Presentation for CANCC
 
Honasa Consumer Limited Impact Report 2024.pdf
Honasa Consumer Limited Impact Report 2024.pdfHonasa Consumer Limited Impact Report 2024.pdf
Honasa Consumer Limited Impact Report 2024.pdf
 
2024: The FAR, Federal Acquisition Regulations, Part 30
2024: The FAR, Federal Acquisition Regulations, Part 302024: The FAR, Federal Acquisition Regulations, Part 30
2024: The FAR, Federal Acquisition Regulations, Part 30
 
2024 UN Civil Society Conference in Support of the Summit of the Future.
2024 UN Civil Society Conference in Support of the Summit of the Future.2024 UN Civil Society Conference in Support of the Summit of the Future.
2024 UN Civil Society Conference in Support of the Summit of the Future.
 
Scaling up coastal adaptation in Maldives through the NAP process
Scaling up coastal adaptation in Maldives through the NAP processScaling up coastal adaptation in Maldives through the NAP process
Scaling up coastal adaptation in Maldives through the NAP process
 
31st World Press Freedom Day - A Press for the Planet: Journalism in the face...
31st World Press Freedom Day - A Press for the Planet: Journalism in the face...31st World Press Freedom Day - A Press for the Planet: Journalism in the face...
31st World Press Freedom Day - A Press for the Planet: Journalism in the face...
 
3 May, Journalism in the face of the Environmental Crisis.
3 May, Journalism in the face of the Environmental Crisis.3 May, Journalism in the face of the Environmental Crisis.
3 May, Journalism in the face of the Environmental Crisis.
 
A Press for the Planet: Journalism in the face of the Environmental Crisis
A Press for the Planet: Journalism in the face of the Environmental CrisisA Press for the Planet: Journalism in the face of the Environmental Crisis
A Press for the Planet: Journalism in the face of the Environmental Crisis
 
Dating Call Girls inBaloda Bazar Bhatapara 9332606886Call Girls Advance Cash...
Dating Call Girls inBaloda Bazar Bhatapara  9332606886Call Girls Advance Cash...Dating Call Girls inBaloda Bazar Bhatapara  9332606886Call Girls Advance Cash...
Dating Call Girls inBaloda Bazar Bhatapara 9332606886Call Girls Advance Cash...
 
Just Call VIP Call Girls In Bangalore Kr Puram ☎️ 6378878445 Independent Fem...
Just Call VIP Call Girls In  Bangalore Kr Puram ☎️ 6378878445 Independent Fem...Just Call VIP Call Girls In  Bangalore Kr Puram ☎️ 6378878445 Independent Fem...
Just Call VIP Call Girls In Bangalore Kr Puram ☎️ 6378878445 Independent Fem...
 
Call Girls in Moti Bagh (delhi) call me [8448380779] escort service 24X7
Call Girls in Moti Bagh (delhi) call me [8448380779] escort service 24X7Call Girls in Moti Bagh (delhi) call me [8448380779] escort service 24X7
Call Girls in Moti Bagh (delhi) call me [8448380779] escort service 24X7
 
Make a difference in a girl's life by donating to her education!
Make a difference in a girl's life by donating to her education!Make a difference in a girl's life by donating to her education!
Make a difference in a girl's life by donating to her education!
 
Election 2024 Presiding Duty Keypoints_01.pdf
Election 2024 Presiding Duty Keypoints_01.pdfElection 2024 Presiding Duty Keypoints_01.pdf
Election 2024 Presiding Duty Keypoints_01.pdf
 
unang digmaang pandaigdig tagalog version
unang digmaang pandaigdig tagalog versionunang digmaang pandaigdig tagalog version
unang digmaang pandaigdig tagalog version
 

GSIPA2M, Parallel session 1, Preventing bad patents - Georgina Gerde